PapersPMID:37169515
L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.
What moved
1 findingHow to read these marks →“Also, total Y-BOCS scores were lower in L-theanine compared to placebo group at week 5 (P = 0.039, Cohen's d = 0.60) and 10 (P = 0.008, Cohen's d = 0.80).”
- Study
- RCT
- Duration
- 2 months
- Dose studied
- L-theanine 100 mg twice daily, oral, added to fluvoxamine
- Population
- Adults 18-60 with DSM-5 OCD and baseline Y-BOCS above 21; fluvoxamine given to both arms as background (100 mg daily, 200 mg daily after week 5); 10-week parallel-group trial; primary outcome was Y-BOCS total decrease from baseline; result recorded is the week-10 contrast
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients aged 18 to 60 years with moderate-to-severe OCD (DSM-5), Y-BOCS score above 21
- Participants
- 50
- Comparator
- placebo
- Duration
- 70 days
- Endpoints measured
- 7
- Declined
- this platform holds no node for the endpoint